Featured News Image Researcher profiles | Apr 14 2025 Wu Tsai Neurosciences Institute Q&A: Favour Nerrise has a plan to spot brain disease early with AI Favour Nerrise, NeuroTech trainee and NeURO-CC mentor, is competing in Stanford’s inaugural 3-Minute Thesis competition on April 17 presenting research that uses at–home tech and artificial intelligence to spot brain disease Image Research news | Apr 9 2025 Stanford Medicine Re-creating neural pathway in dish may speed pain treatment Researchers with the Wu Tsai Neuro–funded Stanford Brain Organogenesis project have rebuilt, in laboratory glassware, the neural pathway that sends informati Image Research news | Mar 17 2025 Wu Tsai Neurosciences Institute Bridging nature and nurture: The brain's flexible foundation from birth By studying never-before-seen details of brain connectivity in human infants, researchers at the Wu Tsai Neurosciences Institute have identified how a balance of innate structure and flexible learning produces our remarkably organized visual brains. Image Wu Tsai Neuro News | Mar 10 2025 Wu Tsai Neurosciences Institute Brain imaging and stimulation technologies receive 2025 Neuroscience:Translate a... Three teams developing promising neurotechnologies with the potential for tremendous impact on human well-being have been named recipients of the 2025 Neuroscience:Translate awards from the Wu Tsai Neurosciences Institute at Stanford. News Filter & Sort Sort by ThemeNeuroHealth News TypeResearch news Press coverage Sort by Newest to oldest Oldest to newest Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine. Image Research news | Aug 29 2018 Stanford Medicine - Scope Opioid system plays key role in ketamine’s antidepressant effects, Stanford stud... For about a dozen years now, the drug ketamine has been a buzz word in psychiatric research circles. Many considered it the most exciting thing to emerge in decades to successfully treat treatment-resistant depression as well as other severe forms of psyc Image Research news | May 22 2017 Stanford Medicine - Scope Stanford researcher explores use of ketamine to treat severe mental illness Stanford researcher Carolyn Rodriguez, MD, PhD, was the first to explore ketamine as a treatment for OCD. Image Press coverage | Jul 29 2016 The Guardian From ketamine to cupboard therapy: the future of mental health treatment With big pharma short on solutions, we talk to people pioneering new ways to beat conditions including anxiety, depression and schizophrenia.
Image Researcher profiles | Apr 14 2025 Wu Tsai Neurosciences Institute Q&A: Favour Nerrise has a plan to spot brain disease early with AI Favour Nerrise, NeuroTech trainee and NeURO-CC mentor, is competing in Stanford’s inaugural 3-Minute Thesis competition on April 17 presenting research that uses at–home tech and artificial intelligence to spot brain disease
Image Research news | Apr 9 2025 Stanford Medicine Re-creating neural pathway in dish may speed pain treatment Researchers with the Wu Tsai Neuro–funded Stanford Brain Organogenesis project have rebuilt, in laboratory glassware, the neural pathway that sends informati
Image Research news | Mar 17 2025 Wu Tsai Neurosciences Institute Bridging nature and nurture: The brain's flexible foundation from birth By studying never-before-seen details of brain connectivity in human infants, researchers at the Wu Tsai Neurosciences Institute have identified how a balance of innate structure and flexible learning produces our remarkably organized visual brains.
Image Wu Tsai Neuro News | Mar 10 2025 Wu Tsai Neurosciences Institute Brain imaging and stimulation technologies receive 2025 Neuroscience:Translate a... Three teams developing promising neurotechnologies with the potential for tremendous impact on human well-being have been named recipients of the 2025 Neuroscience:Translate awards from the Wu Tsai Neurosciences Institute at Stanford.
Image Research news | Jan 9 2023 Wu Tsai Neurosciences Institute The rebirth of psychedelic medicine Researchers at the Wu Tsai Neurosciences Institute are at the forefront of a seismic shift that’s putting a spotlight on once taboo psychedelic substances as a promising new frontier in psychiatric medicine.
Image Research news | Aug 29 2018 Stanford Medicine - Scope Opioid system plays key role in ketamine’s antidepressant effects, Stanford stud... For about a dozen years now, the drug ketamine has been a buzz word in psychiatric research circles. Many considered it the most exciting thing to emerge in decades to successfully treat treatment-resistant depression as well as other severe forms of psyc
Image Research news | May 22 2017 Stanford Medicine - Scope Stanford researcher explores use of ketamine to treat severe mental illness Stanford researcher Carolyn Rodriguez, MD, PhD, was the first to explore ketamine as a treatment for OCD.
Image Press coverage | Jul 29 2016 The Guardian From ketamine to cupboard therapy: the future of mental health treatment With big pharma short on solutions, we talk to people pioneering new ways to beat conditions including anxiety, depression and schizophrenia.
